speb/financial-data huggingface dataset:
SCI.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 8400000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 8400000.00
SCI.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 26600500000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 4627100000.00
SCI.NS income_statement (annual, 2026-03-31) — Normalized Income: 13529200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 4046000000.00
SCI.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 13432100000.00
SCI.NS income_statement (annual, 2026-03-31) — Operating Income: 11216400000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Operating Income: 3248200000.00
SCI.NS income_statement (annual, 2026-03-31) — Operating Revenue: 57797900000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 15132100000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 465799010.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 465799010.00
SCI.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1971500000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1971500000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 743300000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 743300000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 86304900000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 86304900000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 4300000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4300000.00
SCI.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -1463100000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1994000000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1994000000.00
SCI.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 4469900000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1465400000.00
SCI.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2403300000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 621900000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Other Properties: 71984000000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 71984000000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 17200000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 17200000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 30310800000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 30310800000.00
SCI.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS balance_sheet (annual, 2026-03-31) — Payables: 12110800000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Payables: 12110800000.00
SCI.NS income_statement (annual, 2026-03-31) — Pretax Income: 14228100000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 4155900000.00
SCI.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -28400000.00
SCI.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -15504400000.00
SCI.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 44178200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 11262000000.00
SCI.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 10638300000.00
SCI.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -4004000000.00
SCI.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 3048200000.00
SCI.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 536800000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Share Issued: 465799010.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 465799010.00
SCI.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
SCI.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
SCI.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 90962900000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 90962900000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 90958600000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 90958600000.00
SCI.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SCI.NS income_statement (annual, 2026-03-31) — Tax Provision: 698900000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 109900000.00
SCI.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.05
SCI.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.03
SCI.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: 1149400000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Total Assets: 133185000000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 133185000000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 110275900000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 110275900000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Total Debt: 26792500000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 26792500000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 90962900000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 90962900000.00
SCI.NS income_statement (annual, 2026-03-31) — Total Expenses: 46581500000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 11883900000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 42222100000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 42222100000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 85076300000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 85076300000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 20646500000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 20646500000.00
SCI.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
SCI.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SCI.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SCI.NS balance_sheet (annual, 2026-03-31) — Working Capital: 26533100000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 26533100000.00
SCII balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 24261.00
SCII balance_sheet (quarterly, 2025-06-30) — Capital Stock: 739.00
SCII balance_sheet (quarterly, 2025-06-30) — Common Stock: 739.00
SCII balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 8055.00
SCII balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 10525.00
SCII balance_sheet (quarterly, 2025-06-30) — Current Debt: 20420.00
SCII balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 20420.00
SCII balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 30945.00
SCII balance_sheet (quarterly, 2025-06-30) — Invested Capital: 28475.00
SCII balance_sheet (quarterly, 2025-06-30) — Net Debt: 20420.00
SCII balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 8055.00
SCII balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 39000.00
SCII balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 21683571.00
SCII balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 20420.00
SCII balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 10525.00
SCII balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
SCII balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -16945.00
SCII balance_sheet (quarterly, 2025-06-30) — Share Issued: 21683571.00
SCII balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 8055.00
SCII balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 8055.00
SCII balance_sheet (quarterly, 2025-06-30) — Total Assets: 39000.00
SCII balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 8055.00
SCII balance_sheet (quarterly, 2025-06-30) — Total Debt: 20420.00
SCII balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 8055.00
SCII balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 30945.00
SCII balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 39000.00
SCII balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
SCII income_statement (quarterly, 2025-09-30) — +Operating Expense: 42745.00
SCII income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
SCII balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 24261.00
SCII income_statement (quarterly, 2025-09-30) — Basic Average Shares: 21683571.00
SCII income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
SCII cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 0.00
SCII balance_sheet (quarterly, 2025-09-30) — Capital Stock: 739.00
SCII cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 0.00
SCII cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 6525.00
SCII cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 6525.00
SCII cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 6525.00
SCII balance_sheet (quarterly, 2025-09-30) — Common Stock: 739.00
SCII balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -17745.00
SCII balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 22428.00
SCII balance_sheet (quarterly, 2025-09-30) — Current Debt: 137595.00
SCII balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 137595.00
SCII balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 160023.00
SCII income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 21683571.00
SCII income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
SCII income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -42745.00
SCII income_statement (quarterly, 2025-09-30) — EBIT: -42745.00
SCII income_statement (quarterly, 2025-09-30) — EBITDA: -42745.00
SCII cash_flow (quarterly, 2025-09-30) — End Cash Position: 0.00
SCII cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 0.00
SCII balance_sheet (quarterly, 2025-09-30) — Invested Capital: 119850.00
SCII balance_sheet (quarterly, 2025-09-30) — Net Debt: 137595.00
SCII income_statement (quarterly, 2025-09-30) — Net Income: -42745.00
SCII income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -42745.00
SCII income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -42745.00
SCII income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -42745.00
SCII income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -42745.00
SCII cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -42745.00
SCII income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -42745.00
SCII balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -17745.00
SCII balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 142278.00
SCII income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -42745.00
SCII income_statement (quarterly, 2025-09-30) — Normalized Income: -42745.00
SCII cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 0.00
SCII income_statement (quarterly, 2025-09-30) — Operating Income: -42745.00
SCII income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
SCII balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 21683571.00
SCII balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 137595.00
SCII cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 36220.00
SCII income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 42745.00
SCII balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 22428.00
SCII balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
SCII income_statement (quarterly, 2025-09-30) — Pretax Income: -42745.00
SCII balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -42745.00
SCII balance_sheet (quarterly, 2025-09-30) — Share Issued: 21683571.00
SCII balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -17745.00
SCII balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -17745.00
SCII income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SCII income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
SCII balance_sheet (quarterly, 2025-09-30) — Total Assets: 142278.00
SCII balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -17745.00
SCII balance_sheet (quarterly, 2025-09-30) — Total Debt: 137595.00
SCII balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -17745.00
SCII income_statement (quarterly, 2025-09-30) — Total Expenses: 42745.00
SCII balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 160023.00
SCII balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 142278.00
SCII balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
SCII income_statement (quarterly, 2025-12-31) — +Operating Expense: 131198.00
SCII income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
SCII balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1014888.00
SCII cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 0.00
SCII balance_sheet (annual, 2025-12-31) — Capital Stock: 172779548.00
SCII balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1269764.00
SCII balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1269764.00
SCII balance_sheet (annual, 2025-12-31) — Cash Financial: 1269764.00
SCII cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -248512.00
SCII cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 21308.00
SCII cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 21308.00
SCII cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -117314.00
SCII balance_sheet (annual, 2025-12-31) — Common Stock: 172779548.00
SCII balance_sheet (annual, 2025-12-31) — Common Stock Equity: 173899276.00
SCII balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 103536.00
SCII balance_sheet (annual, 2025-12-31) — Current Assets: 1372170.00
SCII balance_sheet (annual, 2025-12-31) — Current Debt: 184357.00
SCII balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 184357.00
SCII balance_sheet (annual, 2025-12-31) — Current Liabilities: 287893.00
SCII income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 147585.00
SCII income_statement (quarterly, 2025-12-31) — EBIT: -131198.00
SCII income_statement (quarterly, 2025-12-31) — EBITDA: -131198.00
SCII cash_flow (quarterly, 2025-12-31) — End Cash Position: 1269764.00
SCII cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -248512.00
SCII balance_sheet (annual, 2025-12-31) — Invested Capital: 174083633.00
SCII income_statement (quarterly, 2025-12-31) — Net Income: 147585.00
SCII income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 147585.00
SCII income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 147585.00
SCII income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 147585.00
SCII income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 147585.00
SCII cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 147585.00
SCII income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 147585.00
SCII balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 173899276.00
SCII balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 36216.00
SCII income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -131198.00
SCII income_statement (quarterly, 2025-12-31) — Normalized Income: 147585.00
SCII cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -248512.00
SCII income_statement (quarterly, 2025-12-31) — Operating Income: -131198.00
SCII income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
SCII balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 24897857.00
SCII balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 184357.00
SCII cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -278783.00
SCII balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 172778783.00
SCII balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 103536.00
SCII balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
SCII balance_sheet (annual, 2025-12-31) — Prepaid Assets: 102406.00
SCII income_statement (quarterly, 2025-12-31) — Pretax Income: 147585.00
SCII balance_sheet (annual, 2025-12-31) — Retained Earnings: 104840.00
SCII balance_sheet (annual, 2025-12-31) — Share Issued: 24897857.00
SCII balance_sheet (annual, 2025-12-31) — Stockholders Equity: 173899276.00
SCII balance_sheet (annual, 2025-12-31) — Tangible Book Value: 173899276.00
SCII income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SCII income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
SCII balance_sheet (annual, 2025-12-31) — Total Assets: 174187169.00
SCII balance_sheet (annual, 2025-12-31) — Total Capitalization: 173899276.00
SCII balance_sheet (annual, 2025-12-31) — Total Debt: 184357.00
SCII balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 173899276.00
SCII income_statement (quarterly, 2025-12-31) — Total Expenses: 131198.00
SCII balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 287893.00
SCII balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 172814999.00
SCII balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
SCII balance_sheet (annual, 2025-12-31) — Working Capital: 1084277.00
SCII income_statement (quarterly, 2026-03-31) — +Operating Expense: 184029.00
SCII income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
SCII balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 0.00
SCII income_statement (quarterly, 2026-03-31) — Basic Average Shares: 24897857.00
SCII income_statement (quarterly, 2026-03-31) — Basic EPS: 0.06
SCII cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1269764.00
SCII balance_sheet (quarterly, 2026-03-31) — Capital Stock: 174569253.00
SCII balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 930741.00
SCII balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 930741.00
SCII balance_sheet (quarterly, 2026-03-31) — Cash Financial: 930741.00
SCII cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -184357.00
SCII cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -154666.00
SCII cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 63337.00
SCII cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 63337.00
SCII cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -34242.00
SCII cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 29095.00
SCII cash_flow (quarterly, 2026-03-31) — Changes In Cash: -339023.00
SCII balance_sheet (quarterly, 2026-03-31) — Common Stock: 174569253.00
SCII balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 175505220.00
SCII balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 166873.00
SCII balance_sheet (quarterly, 2026-03-31) — Current Assets: 1089868.00
SCII balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 166873.00
SCII income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 24897857.00
SCII income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.06
SCII income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1605944.00
SCII income_statement (quarterly, 2026-03-31) — EBIT: -184029.00
SCII income_statement (quarterly, 2026-03-31) — EBITDA: -184029.00
SCII cash_flow (quarterly, 2026-03-31) — End Cash Position: 930741.00
SCII cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -184357.00
SCII cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -154666.00
SCII income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 184029.00
SCII income_statement (quarterly, 2026-03-31) — Interest Income: 1789973.00
SCII income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1789973.00
SCII balance_sheet (quarterly, 2026-03-31) — Invested Capital: 175505220.00
SCII income_statement (quarterly, 2026-03-31) — Net Income: 1605944.00
SCII income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1605944.00
SCII income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1605944.00
SCII income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1605944.00
SCII income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1605944.00
SCII cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1605944.00
SCII income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1605944.00
SCII income_statement (quarterly, 2026-03-31) — Net Interest Income: 1789973.00
SCII cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -184357.00
SCII income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1789973.00
SCII cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -184357.00
SCII balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 175505220.00
SCII balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 13737.00
SCII income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -184029.00
SCII income_statement (quarterly, 2026-03-31) — Normalized Income: 1605944.00
SCII cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -154666.00
SCII income_statement (quarterly, 2026-03-31) — Operating Income: -184029.00
SCII income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
SCII balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 24897857.00
SCII income_statement (quarterly, 2026-03-31) — Other Gand A: 184029.00
SCII cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -1789705.00
SCII balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 174568488.00
SCII balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 166873.00
SCII balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
SCII balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 159127.00
SCII income_statement (quarterly, 2026-03-31) — Pretax Income: 1605944.00
SCII cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -184357.00
SCII balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 935967.00
SCII income_statement (quarterly, 2026-03-31) — Selling General And Administration: 184029.00
SCII balance_sheet (quarterly, 2026-03-31) — Share Issued: 24897857.00
SCII cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -184357.00
SCII balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 175505220.00
SCII balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 175505220.00
SCII income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SCII income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
SCII balance_sheet (quarterly, 2026-03-31) — Total Assets: 175672093.00
SCII balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 175505220.00
SCII balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 175505220.00
SCII income_statement (quarterly, 2026-03-31) — Total Expenses: 184029.00
SCII balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 166873.00
SCII balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 174582225.00
SCII balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
SCII income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -184029.00
SCII balance_sheet (quarterly, 2026-03-31) — Working Capital: 922995.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -36800000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
SCILAL.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 117600000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 100000.00
SCILAL.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 100000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Current Debt: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 3000.00
SCILAL.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 500000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Goodwill: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 0.00
SCILAL.NS income_statement (annual, 2022-03-31) — Interest Income: 58200000.00
SCILAL.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 58200000.00
SCILAL.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: 0.00
SCILAL.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 100000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 23763800000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 56100000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
SCILAL.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 100000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: -100000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Other Payable: 14232.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 36600000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SCILAL.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: -800000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 0.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 23850000000.00
SCILAL.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 0.00
SCILAL.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 500000.00
SCILAL.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00
SCILAL.NS income_statement (annual, 2023-03-31) — +Operating Expense: 67943000.00
SCILAL.NS income_statement (annual, 2023-03-31) — +Total Revenue: 125000000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 100000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -43200000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 700000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 3800000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 465799010.00
SCILAL.NS income_statement (annual, 2023-03-31) — Basic EPS: 0.76
SCILAL.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 100000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 117600000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -10600000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 900000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 100100000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 10000100000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 100000000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 100000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -7400000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Change In Payable: -16500000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -23900000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 100000000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Common Stock: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 31741300000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 10000000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 198900000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Current Assets: 10305400000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2437200000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Depreciation: 7600000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 7600000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 7600000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 7600000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 465799010.00
SCILAL.NS income_statement (annual, 2023-03-31) — Diluted EPS: 0.76
SCILAL.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 355500000.00
SCILAL.NS income_statement (annual, 2023-03-31) — EBIT: 175900000.00
SCILAL.NS income_statement (annual, 2023-03-31) — EBITDA: 183500000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — End Cash Position: 100100000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -100000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -243500000.00
SCILAL.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 31643000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 23947700000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Gross Profit: -73900000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Interest Expense: 100000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 100000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Interest Income: 508000000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 508000000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 243600000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Inventory: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 31741300000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 333000000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 23100000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 3800000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 23763800000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 900000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 900000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 56300000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 190000000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Net Income: 355500000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 355500000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 355500000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 355500000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 355500000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 175800000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 355500000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Net Interest Income: 507900000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 100000000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 507900000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Net PPE: 23904500000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -10600000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 31741300000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 85300000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 183500000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Normalized Income: 355500000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -232900000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Operating Income: -141843000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Operating Revenue: 125000000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 465799010.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 4658000000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -507900000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -100000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 508000000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 28700000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Other Properties: 23893600000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 292400000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 9900000000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Payables: 100000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 12200000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Pretax Income: 175800000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -2870800000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -10600000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 198900000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 7600000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: -100000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 24205500000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 2970800000.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
SCILAL.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 31643000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Share Issued: 465799010.00
SCILAL.NS income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 31741300000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 31741300000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
SCILAL.NS income_statement (annual, 2023-03-31) — Tax Provision: -179700000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
SCILAL.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 0.00
SCILAL.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -74500000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Total Assets: 34264700000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 31741300000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Total Debt: 900000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 31741300000.00
SCILAL.NS income_statement (annual, 2023-03-31) — Total Expenses: 266843000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2523400000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 23959300000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 86200000.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
SCILAL.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 0.00
SCILAL.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SCILAL.NS balance_sheet (annual, 2023-03-31) — Working Capital: 7868200000.00
SCILAL.NS income_statement (annual, 2024-03-31) — +Operating Expense: 156500000.00
SCILAL.NS income_statement (annual, 2024-03-31) — +Total Revenue: 172200000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 235200000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 45400000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -50100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
SCILAL.NS income_statement (annual, 2024-03-31) — Amortization: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 700000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 3800000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 465799010.00
SCILAL.NS income_statement (annual, 2024-03-31) — Basic EPS: 1.02
SCILAL.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 100100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 124900000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -77100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 900000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 4658000000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 33000000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 10455000000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 33000000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -3616600000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 36000000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Change In Payable: 235000000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -45400000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -3391000000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -67200000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Common Stock: 4658000000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 32216200000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 80200000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 247700000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Current Assets: 10913000000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2742500000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Depreciation: 6900000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 6900000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 6900000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 6900000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 465799010.00
SCILAL.NS income_statement (annual, 2024-03-31) — Diluted EPS: 1.02
SCILAL.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 474900000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 0.00
SCILAL.NS income_statement (annual, 2024-03-31) — EBIT: 551100000.00
SCILAL.NS income_statement (annual, 2024-03-31) — EBITDA: 558000000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — End Cash Position: 33000000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -100000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -3871600000.00
SCILAL.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 27900000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 45400000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 24025200000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Gross Profit: -75500000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Interest Expense: 100000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 100000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Interest Income: 817200000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 817200000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 682800000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Inventory: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 32216200000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 3727400000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 22500000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 3800000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 23763800000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 900000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 900000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 56300000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 34300000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Net Income: 474900000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 474900000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 474900000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 474900000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 474900000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 551000000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 474900000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Net Interest Income: 817100000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 3121700000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 0.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 0.00
SCILAL.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 817100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Net PPE: 23975100000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -77100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 32216100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 0.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 22300000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 558000000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Normalized Income: 474900000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -3794500000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Operating Income: -232000000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Operating Revenue: 172200000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 465799010.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 13200000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 19400000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 27558300000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 100000.00
SCILAL.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -817100000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 100000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 817200000.00
SCILAL.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 115600000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Other Payable: 5700000.00
SCILAL.NS balance_sheet (annual, 2024-03-31) — Other Properties: 23894900000.00